| 000 | 01622 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516064934.0 | ||
| 264 | 0 | _c20120430 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1744-8301 | ||
| 024 | 7 |
_a10.2217/fon.11.121 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYan, Alan | |
| 245 | 0 | 0 |
_aAdipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition. _h[electronic resource] |
| 260 |
_bFuture oncology (London, England) _cDec 2011 |
||
| 300 |
_a1457-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdipocytes _xcytology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, Reporter _xgenetics |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphangiogenesis _xdrug effects |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aStem Cells _xdrug effects |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor C _xpharmacology |
| 700 | 1 | _aAvraham, Tomer | |
| 700 | 1 | _aZampell, Jamie C | |
| 700 | 1 | _aHaviv, Yosef S | |
| 700 | 1 | _aWeitman, Evan | |
| 700 | 1 | _aMehrara, Babak J | |
| 773 | 0 |
_tFuture oncology (London, England) _gvol. 7 _gno. 12 _gp. 1457-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/fon.11.121 _zAvailable from publisher's website |
| 999 |
_c21338891 _d21338891 |
||